NCT04320212

Brief Summary

Surgical procedures on the spine and spinal cord are common and are performed for a wide variety of diseases. They range from minimally invasive, single-level decompression to highly complex, multi-stage extensive reconstruction. Operative procedures for degenerative spine diseases and herniated discs are most common in those under 60 years of age. While those over 60 years of age most commonly undergo spine surgery for spinal stenosis Patients undergoing spine surgery experience severe pain in the postoperative period. Recent studies show that the incidence of acute postoperative pain following spine surgery vary from 30 to 64%. Postoperative pain may also increase morbidity and incidence of complications and prolong postoperative rehabilitation. In addition, it is a risk factor for development of chronic pain syndromes Postoperative pain is usually treated with oral or intravenous opioids in combination with non-steroidal anti-inflammatory drugs. However, they often results in insufficient pain control and side effects such as respiratory depression, nausea, and vomiting. Epidural anaesthesia and analgesia have been shown to be superior to intravenous analgesia. The former is better with respect to pain quality, incidence of side effects, pulmonary, cardiac, and gastrointestinal dysfunction. However, it may be associated with hemodynamic instability. Migration of the epidural catheter with unpredictable absorption of the local anaesthetics remains a challenge to the anaesthetists. The Erector Spinae block proved to be efficient in controlling post-operative pain. It is a simple interfascial plane block, published in 2016. It provides effective analgesia for 24 hours in patients undergoing lumbar spine surgery. Therefore, a prospective, randomized study was designed to compare the analgesic and side effects of the epidural analgesia with the Erector Spinae block in patients undergoing lumbar spine surgery. To our knowledge, this is the first clinical trial that compares the Erector Spinae block with the epidural analgesia in a variety of lumbar spine surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
8 days until next milestone

Study Start

First participant enrolled

April 1, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2021

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2021

Completed
Last Updated

August 16, 2021

Status Verified

August 1, 2021

Enrollment Period

12 months

First QC Date

December 19, 2019

Last Update Submit

August 12, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • time to first analgesic request

    minutes

    from the time of performance of the intervention till the first analgesic requirement during the 24 hours postoperative

Secondary Outcomes (5)

  • The numeric rate scale (NRS)

    5 minutes after extubation,1 hour, 2 hours, 4 hours, 8 hours, 12 hours and 24 hour postoperative

  • postoperative morphine consumption

    5 minutes after extubation till 24 hour postoperative

  • postoperative diclofenac consumption

    5 minutes after extubation till 24 hour postoperative

  • systolic blood pressure

    every 10 minutes from skin incision to skin closure and at 2, 4 hours post operatively.

  • heart rate

    every 10 minutes from skin incision to skin closure and at 2, 4 hours post operatively.

Study Arms (2)

lumber epidural analgesia

ACTIVE COMPARATOR

: the patient will be placed in the lateral position, Lidocaine will be given using 5 ml syringe and a 18 G Tuohy needle will be introduced in the epidural space, using the ultrasound, under strict aseptic precautions. The ultrasound probe will be placed 90 degrees into transverse orientation and slided cephalad or caudad to obtain the transverse interspinous view (TI view) 2 levels above the operation level. patient will receive 20 ml of 0.25% plain bupivacaine after negative aspiration for blood or cerebrospinal fluid. Then, the patient will be placed in prone position to start the surgical procedure

Procedure: lumber epidural analgesia

erector spinae analgesia

ACTIVE COMPARATOR

the patient will be placed in the prone position. Then, the Erector Spinae block will be given by a high-frequency linear ultrasound transducer. The Erector Spinae muscle and transverse process will be then identified, and a 18 G Tuohy needle will be advanced, using the in-plane approach, in cephalad-to-caudal direction, through the interfascial plane between the Erector Spinae and the underlying transverse process under strict aseptic precautions until the tip is deep to erector spinae muscle. The block will be performed bilaterally by injecting 40 mL of 0.25% bupivacaine (20 mL into each side)

Procedure: erector spinae analgesia

Interventions

the lumber epidural analgesia will be given after induction of general anesthesia.

lumber epidural analgesia

the erector spinae analgesia will be given after induction of general anesthesia.

erector spinae analgesia

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I, II patients
  • Aged 18-60 years
  • Undergoing elective lumbar spine decompression and fusion surgery, using the posterior approach, under general anaesthesia.

You may not qualify if:

  • Patients with severe cardiac diseases as ischemic heart disease, rheumatic valve disorders and cardiomyopathy.
  • Contraindication to neuroaxial anaesthesia e.g. patients on anticoagulants, infection at the injection site and coagulopathy
  • Hypersensitivity to the local anaesthetics used.
  • Patient refusal.
  • Neurologic deficits in the form of sensory loss, motor weakness or preexisting pain symptoms due to neurologic diseases apart from back pain associated with the planned operation.
  • Patients with previous back surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alainy Hospital

Cairo, Manial, 11562, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2019

First Posted

March 24, 2020

Study Start

April 1, 2020

Primary Completion

March 20, 2021

Study Completion

March 22, 2021

Last Updated

August 16, 2021

Record last verified: 2021-08

Locations